Filing Details

Accession Number:
Form Type:
Zero Holdings:
Publication Time:
2017-01-04 17:28:28
Reporting Period:
Filing Date:
Accepted Time:
2017-01-04 17:28:28
SEC Url:
Form 4 Filing
Cik Name Symbol Sector (SIC) IRS No
1001316 Tg Therapeutics Inc. TGTX Pharmaceutical Preparations (2834) 363898269
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1538845 A Sean Power 2 Gansevoort St
9Th Floor
New York NY 10014
Cfo, Secretary And Treasurer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2016-12-30 100,000 $0.00 516,256 No 4 A Direct
Common Stock Disposition 2017-01-04 8,816 $4.55 507,440 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
  1. Reflects a grant of restricted shares that will vest according to the following schedule: 17.5% on January 1, 2018; 17.5% on January 1, 2019; 35% on the later to occur of: (a) the date that the Company's Market Capitalization is $100 million greater than the Market Capitalization on December 31, 2016 and (b) June 30, 2019; and 30% on performance based thresholds associated with the Company?s clinical programs.
  2. Includes shares of restricted Common Stock, which vest over various time periods.
  3. In connection with the vesting of 15,000 shares on January 1, 2017, these shares were sold by the Company's restricted stock administrator in order to satisfy Mr. Power's tax withholding obligations. Mr. Power had no discretion with respect to such sale, which was transacted automatically in accordance with the Company's corporate policies regarding the vesting of restricted stock.
  4. Represents the weighted average sales price.